CHICAGO ( TheStreet) --Welcome to TheStreet's live-blog coverage of the American Society of Clinical Oncology (ASCO) annual meeting. It's Monday, the third full day of data presentations at the largest annual gathering of cancer drug researchers in the world. More importantly, investors get the first chance to trade cancer drug stocks today following a weekend of data presentations.
On the schedule for today: An important update from Ariad Pharmaceuticals (ARIA - Get Report) and the pivotal study of ponatinib in chronic myeloid leukemia. Also, presentation from Onyx Pharmaceuticals (ONXX) and Bayer of phase III data from a study of regorafenib in gastrointestinal stromal tumors (GIST).
>To contact the writer of this article, click here: Adam Feuerstein. >To follow the writer on Twitter, go to http://twitter.com/adamfeuerstein. >To submit a news tip, send an email to: firstname.lastname@example.org. Follow TheStreet on Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts